SCHEMBL8205322

SCHEMBL8205322

CCOC(=N)c1ccc2ccccc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 1/20 0.53
PLG P00747 1/20 0.53
PLAU P00749 1/20 0.53
KLKB1 P03952 1/20 0.53
KLK1 P06870 1/20 0.53
PRSS1 P07477 1/20 0.53
DGAT1 O75907 1/20 0.49
CES2 O00748 1/20 0.47
CES1 P23141 1/20 0.47
PTGS1 P23219 1/20 0.46
PTGS2 P35354 1/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
ALDH1A1 P00352 1/20 0.46
P2RY12 Q9H244 1/20 0.46
GAA P10253 1/20 0.45
KDM4E B2RXH2 1/20 0.45
HPGD P15428 1/20 0.45
PTPN1 P18031 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30278793 1.00 F2 (0.53) F2PLGPLAUKLKB1KLK1
Hydrochloric Acid SCHEMBL14118767 0.98 F2 (0.52) F2PLGPLAUKLKB1KLK1
SCHEMBL22062269 0.82 CES2 (0.49) F2PLGPLAUKLKB1KLK1
SCHEMBL30684671 0.80 CA12 (0.59) CES2CES1NPC1RAB9ASMN1; SMN2
SCHEMBL571295 0.80 CA12 (0.59) CES2CES1NPC1RAB9ASMN1; SMN2
SCHEMBL13108706 0.80 DGAT1 (0.62) PRSS1DGAT1SMN1; SMN2ALDH1A1HPGD
Hydrochloric Acid SCHEMBL27783226 0.79 CA12 (0.57) CES2CES1NPC1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL27804731 0.79 CA12 (0.57) CES2CES1NPC1RAB9ASMN1; SMN2
SCHEMBL437904 0.78 DGAT1 (0.52) F2DGAT1NPC1RAB9ASMN1; SMN2
SCHEMBL13108721 0.78 DGAT1 (0.52) F2DGAT1NPC1ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230140395-A1 NOVEL IMIDAZOLE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND USE THEREOF INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS (KR) 2023-05-04 US disclosed
US-20230140395-A1 NOVEL IMIDAZOLE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND USE THEREOF INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS (KR) 2023-05-04 US disclosed
WO-2020022787-A1 NOVEL IMIDAZOLE DERIVATIVE HAVING JNK INHIBITORY ACTIVITY, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 삼진제약주식회사 2020-01-30 WO disclosed
US-10301291-B2 Imidazole derivative having JNK inhibitory activity and use thereof SAMJIN PHARMACEUTICAL CO., LTD. (KR) 2019-05-28 US disclosed
US-20190031645-A1 NOVEL IMIDAZOLE DERIVATIVE HAVING JNK INHIBITORY ACTIVITY AND USE THEREOF INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS (KR) 2019-01-31 US disclosed
US-9929356-B2 Light-emitting element, light-emitting device, electronic appliance, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2018-03-27 US disclosed
US-9929356-B2 Light-emitting element, light-emitting device, electronic appliance, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2018-03-27 US disclosed
US-9406894-B2 Organometallic complex, organic light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2016-08-02 US disclosed
US-9406894-B2 Organometallic complex, organic light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2016-08-02 US disclosed
US-20140151662-A1 Light-Emitting Element, Light-Emitting Device, Electronic Appliance, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-06-05 US disclosed
US-20140151662-A1 Light-Emitting Element, Light-Emitting Device, Electronic Appliance, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-06-05 US disclosed
US-20120305896-A1 Organometallic Complex, Organic Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-12-06 US disclosed
US-6096144-A TREATING WITH ACIDIC OR ALKALINE SOLUTION OF CONJUGATED UNSATURATED COMPOUND WITH AT LEAST 5 BONDS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2000-08-01 US disclosed
US-5858571-A TREATING A PULVERIZED HYDROGEN ABSORBING ALLOY WITH A SOLUTION COMPRISING A CONJUGATED UNSATURATED COMPOUND SHIN-ETSU CHEMICAL CO., LTD. (JP) 1999-01-12 US disclosed
EP-0172427-B1 PROCESS FOR PRODUCTION OF VINYL CHLORIDE POLYMER Shin-Etsu Chemical Co., Ltd. (JP) 1989-07-05 EP disclosed
US-4758639-A Process for production of vinyl polymer SHIN-ETSU CHEMICAL CO., LTD. (JP) 1988-07-19 US disclosed
US-4757124-A Suspension or emulsion polymerizing vinyl chloride monomer or mixture of vinyl chloride with vinyl monomer copolymerizable therewith in reactor with walls coated with antiscaling compound containing dye or pigments SHIN-ETSU CHEMICAL CO., LTD. (JP) 1988-07-12 US disclosed
EP-0172427-A2 Process for production of vinyl chloride polymer Shin-Etsu Chemical Co., Ltd. (JP) 1986-02-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190031645-A1 NOVEL IMIDAZOLE DERIVATIVE HAVING JNK INHIBITORY ACTIVITY AND USE THEREOF MAPKAPK2, MAPKAPK3, MAP3K7 F2 4835/4885PLG 4644/4885PLAU 3418/4885
US-10301291-B2 Imidazole derivative having JNK inhibitory activity and use thereof MAPKAPK2, MAPKAPK3, MAP3K7 F2 4769/4885PLG 4518/4885PLAU 3111/4885
US-20120305896-A1 Organometallic Complex, Organic Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device LAGE3, CYBA, CRY1 F2 285/4885PLG 4349/4885PLAU 4019/4885
US-20230140395-A1 NOVEL IMIDAZOLE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND USE THEREOF MAPKAPK3, MAPK3, MAP3K3 F2 4538/4885PLG 4522/4885PLAU 4114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.